Added to YB: 2025-04-21
Pitch date: 2025-03-31
LXS.DE [neutral]
LANXESS Aktiengesellschaft
-36%
current return
Author Info
No bio for this author
Company Info
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide.
Market Cap
EUR 1.5B
Pitch Price
EUR 27.70
Price Target
N/A
Dividend
0.57%
EV/EBITDA
15.44
P/E
-2.64
EV/Sales
0.63
Sector
Chemicals
Category
N/A
Longleaf Partners International Fund Portfolio Holding: LANXESS Aktiengesellschaft
LXS.DE (holding update): German specialty chemical co up on Ukraine war resolution hopes & Merz's €500B infra plan. Q4 strong with cost savings on track. Urethanes sale at €500M will reduce debt to 3x. 2025 EBITDA guidance conservative at +10%. Undervalued Envalior JV stake worth 35% of market cap with 12x EBITDA put option from Apr 2026.
Read full article (2 min)